Journal article icon

Journal article

In vivo assessments to detect antimalarial resistance

Abstract:
In vivo drug clinical trials are the gold standard for assessing the therapeutic efficacy of antimalarials. They must be conducted in a rigorous and standardized manner so that the resistance of antimalarial drugs can be compared both in time and in space. This chapter presents the methodology for conducting such clinical studies of antimalarials for the treatment of uncomplicated malaria and describes the logistical difficulties and limitations of this methodology. Finally it highlights the importance of such knowledge in preventing resistance, in prolonging the utility of existing antimalarial drugs, and in ensuring that all individuals and populations suffering from malaria get the right malaria treatment at the right time.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/978-1-4939-9550-9_8

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0002-7849-3293
More by this author
Institution:
University of Oxford
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author


Publisher:
Humana Press
Journal:
Malaria Control and Elimination More from this journal
Volume:
2013
Pages:
105-121
Series:
Methods in Molecular Biology
Publication date:
2019-07-03
DOI:
EISSN:
1940-6029
ISSN:
1064-3745
Pmid:
31267497
ISBN:
9781493995509


Language:
English
Keywords:
Pubs id:
pubs:1031930
UUID:
uuid:8df98b10-2112-49c1-b61c-168e9d369d09
Local pid:
pubs:1031930
Source identifiers:
1031930
Deposit date:
2019-07-18
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP